Travocort COBS Cream
ٹراؤ کارت کریم
NAME OF THE MEDICINAL PRODUCT Travocort Cream
QUALITATIVE AND QUANTITATIVE COMPOSITION 1 Travocort cream contains 10 mg (1%) isoconazole nitrate and 1 mg (0.15) diflucartolone-21-valerate.
PHARMACEUTICAL FORM https://luckasluck.click/travocort-cobs-cream/
Cream
Indication(s)
initial or interim treatment of those superficial fungal infections of the skin which are accompanied by highly inflammatory or eczematous skin conditions, eg. in the region of the hands, the interdigital spaces of the feet, and in the inguinal and genital regions.
Dosage and method of administration Method of administration
Dosage regimen:
Travocort should be applied twice daily to the diseased areas of skin. The treatment with Travocort must be terminated after regression of the inflammatory or eczematous skin condition, at the latest, however, after 2 weeks, and the therapy continued or followed up with a glucocorticaid-free anti-fungal preparation. This applies In particular foruse in the inguinal and genital regions.
Tuberculous or syphilitic processes in the area to be treated, virus diseases (eg. varicella, herpes zoster), rosacea, perioral dermatitis and post vaccination skin reactions in the area to be treated. Hypersensitivity to the active substances or to any of the excipients.
Special warnings and precautions for use:
Specific additional therapy is required for bacterial infections of the skin.
Travocort should not be allowed to come into contact with the eyes when being applied to the face.
Extensive application of topical glucocorticoids to large areas of the body or for prolonged periods of time, in particular under occlusion, may increase the risk of systemic side effects. As known from systemic glucocorticoids, glaucoma may also develop from using local glucocorticoids ing. after large-dosed or extensive application over a prolonged period, ecclusive dressing techniques, or application to the skin around the ryes
Also physician should advise the patients on hygienic measures during the treatment. If Travocart is applied to the genital regions, excipients liquid paraffin and soft paraffin may cause damage of latex the products for barrier methods such as condoms and diaphragms used concomitantly, thus impairing their effectiveness
Interaction with other medicinal products and other forms of Interaction
No interaction studies have been performed.
Fertility, pregnancy and lactation:
There are no data from the use of isoconazole nitratediflucertolone.
23 valerate in pregnant women. Studies in animals Omice, rats and rabbits) have shown reproductive traicity for diftucortoione 21-valerate. In general, the use of topical.
first trimester of pregnancy.
Preclinical data did not indicate any risk on fertility
Summary of the safety profile
In clinical studies, most frequently observed adverse reactions Included application site irritation and application site burning.
Tabulated list of adverse reactions
System Organ Class Commen
General
and
Application site
Application
Frequency not
admanstra condi
witason,
ryness
Application te
nides
Description of selected adverse reactions:
Overdose:
Cetostearyl alcohol
Disodium edetate
Paraffin, iquid
Paraffin, white soft
Polysorbate 60
Water, purified
Mirutan stearate
Incompatibilities None:
Shelf life;
Please see carton
Special precautions for storage:
Store below 30°C
Nature and contents of container
Aluminum Tube
Travocort Cream: 1x10g Tube
Keep out of the reach of children.
Manufactured by: OBS Pharma (Pvt.) Ltd. 108, Quaid-e-Azam Industrial Estate, Kot Lakhpat, Lahore.
جالات فریق استعمال
ڈاکٹر کے مشورے کے مطابق استعمال کریں۔ 300 سے کم درجہ حرارت میں رکھیں۔ بچوں کی آئی سے دور رکھیں۔